Unasnemab

Product Description: Unasnemab (MT-3921) is a humanised IgG1 monoclonal antibody that binds to repulsive guidance molecule A (RGMa). Unasnemab improves locomotor function and promotes neuroregeneration and can be used for the research of spinal cord injury[1].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]Saori Obayashi. Phase 2 Trial of MT-3921 initiated for treatment of spinal cord injury.

Molecular Weight: N/A

Compound Purity: 95.82

Research Area: Neurological Disease

Solubility: H2O

Target: Others

• SKU: MEXHY-P99959-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99959-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated